or
forgot password
  • cancer clinical trials in indianapolis, IN

  • Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Saint Vincent Oncology Center
    Indianapolis, Indiana 46260
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Franciscan St. Francis Health
    Indianapolis, Indiana 46237
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
    Investigative Clinical Research of Indiana
    Indianapolis, Indiana 46254
    Pancreatic Cancer, Ductal Adrenocarcinoma, Exocrine Pancreatic Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Saint Vincent Hospital and Health Services

    Trial Locations
    Saint Vincent Hospital and Health Services
    Riley Hospital for Children
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
    IU Health Central Indiana Cancer Centers
    Indianapolis, Indiana 46219
    Renal Cell Carcinoma
    Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
    Indiana University Medical Center
    Indianapolis, Indiana 46202
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
    Riley's Children Cancer Center at Riley Hospital for Children
    Indianapolis, Indiana 46202-5225
    Adrenocortical Carcinoma, Gastrointestinal Carcinoid Tumor, Kidney Cancer, Neuroblastoma, Retinoblastoma, Sarcoma
    Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
    Community Regional Cancer Care at Community Hospital North

    Trial Locations
    Community Regional Cancer Care at Community Hospital North
    Community Regional Cancer Care at Community Hospital East
    Lung Cancer
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    St. Vincent Oncology Center
    Indianapolis, Indiana 46260
    Brain and Central Nervous System Tumors
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    Clarian Health - Methodist Hospital
    Indianapolis, Indiana 46202
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
    Franciscan St. Francis Health
    Indianapolis, Indiana 46237
    Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma
    Ovarian Cancer Vaccine for Patients in Remission
    Indiana University Simon Cancer Center
    Indianapolis, Indiana 46202
    Epithelial Ovarian Cancer
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    Indiana University

    Trial Locations
    Indiana University
    Investigative Clinical Research of Indiana, LLC
    Pancreatic Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Central Indiana Cancer Centers
    Indianapolis, Indiana 46227
    Metastatic Breast Cancer
    Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
    Indiana University Medical Center
    Indianapolis, Indiana 46202
    Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Hepatosplenic T-cell Lymphoma, HIV-associated Hodgkin Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia
    A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
    Indiana University Riley Hospital for Children
    Indianapolis, Indiana 46202
    Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    Indiana University Cancer Center Clinical Research Office
    Indianapolis, Indiana 46202
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    Indiana University Cancer Center Clinical Research Office
    Indianapolis, Indiana 46202
    Multiple Myeloma
    A Study in Head and Neck Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Indianapolis, Indiana 46227
    Head and Neck Cancer
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Indiana University Medical Center

    Trial Locations
    Indiana University Medical Center
    Saint Vincent Oncology Center
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Riley Hospital for Children
    Indianapolis, Indiana 46202
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
    Indiana University (IUPUI)
    Indianapolis, Indiana 46268
    HER2 Amplified Breast Cancer, Metastatic or Advanced Breast Cancer
    A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)
    Indiana University School of Medicine Simon Cancer Center 535 Barnhill Drive, RT 380
    Indianapolis, Indiana 46202
    Disease, Hodgkin
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Indiana University Hospital/Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202
    Breast Cancer
    Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
    Indiana University Melvin and Bren Simon Cancer Center

    Trial Locations
    Indiana University Melvin and Bren Simon Cancer Center
    St. Vincent Oncology Center
    Cervical Cancer
    Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
    Indiana University Melvin and Bran Simon Cancer Center
    Indianapolis, Indiana 46202
    Advanced Non-clear Cell Renal Cell Carcinoma
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    Indiana University Simon Cancer Center

    Trial Locations
    Indiana University Simon Cancer Center
    St. Francis Medical Group Oncology and Hematology Associates
    Peripheral T-cell Lymphoma
    A Study of IMC-RON8 in Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Indianapolis, Indiana 46227
    Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Veterans Affairs Medical Center - Indianapolis
    Indianapolis, Indiana 46202
    Kidney Cancer
    Childhood Cancer Survivor Study
    Indiana University/Riley Hospital for Children
    Indianapolis, Indiana 46202
    Cancer
    Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients
    IU Simon Cancer Center
    Indianapolis, Indiana 46202
    Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma
    Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Neoplasm Metastases
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    William N. Wishard Memorial Hospital
    Indianapolis, Indiana 46202
    Breast Cancer
    Ceprotin Treatment Registry
    Indiana Hemophilia & Thrombosis Center, Inc.
    Indianapolis, Indiana 46260
    Severe Congenital Protein C Deficiency
    Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Saint Vincent Oncology Center
    Indianapolis, Indiana 46260
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Indiana University Medical Center
    Indianapolis, Indiana 46202
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Indiana University Melvin and Bren Simon Cancer Center

    Trial Locations
    Indiana University Melvin and Bren Simon Cancer Center
    St. Vincent Oncology Center
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
    Riley Hospital for Children
    Indianapolis, Indiana 46202
    Unspecified Childhood Solid Tumor, Protocol Specific
    Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma
    IU Simon Cancer Center
    Indianapolis, Indiana 46202
    Multiple Myeloma
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Indiana University Medical Center

    Trial Locations
    Indiana University Medical Center
    Richard L. Roudebush Veterans Affairs Medical Center
    Wishard Hospital
    Central Indiana Cancer Centers - Indianapolis
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Indiana University Melvin and Bren Simon Cancer Center

    Trial Locations
    Indiana University Melvin and Bren Simon Cancer Center
    William N. Wishard Memorial Hospital
    Colorectal Cancer